The European Union has agreed on a new approach to the cultivation of Genetically Modified Organisms (GMO) which allows member states to ban or restrict GMOs in their territory. The agreement should mark the end of a decade of legal problems, but in the context of ongoing EU-US free trade negotiations, vocal GMO opposition from member states and civil society is unlikely to subside.
The European Commission is reviewing its impact assessment guidelines amid accusations that science is becoming increasingly politicised and scientists manipulated by policymakers and powerful interest groups.
In the autumn of 2014, a new team of commissioners will take charge of the EU executive. As Europe's economic storms calm down, the next Commission can set its sights on a number of long-term challenges when drafting its programme.
The number one killer in Europe, cardiovascular disease, is set to become an even greater burden on the already recession-hit continent's health systems. Therefore, the Commission is now trying to tackle the growing problem with different initiatives and health programmes.
On 22-25 May, EU citizens cast their ballots to elect 751 members of the European Parliament. But MEPs will not be the only ones to perform a game of musical chairs: 2014 will also bring about change in many of the top positions in the EU.
Rising levels of cancers and fertility problems have attracted scientists’ attention to endocrine disrupting chemicals, with some calling for strict regulation of the substances, in line with the precautionary principle.